Aurinia Pharma's Phase 2b Data Lifts Stock, Suggests Big Potential
April 21, 2017 at 09:16 AM EDT
Elemer Piros of Cantor Fitzgerald maintains an Overweight rating on Aurinia Pharmaceuticals Inc (NASDAQ: AUPH)'s stock with a $14 price ...